Zydus Lifesciences gets CDSCO nod to begin Phase II clinical trial of ZYIL1 in Amyotrophic Lateral Sclerosis patients Ruchika Sharma25 Oct 2023 11:16 AM ISTThe Phase II clinical trial will study safety, tolerability, pharmacokinetics and pharmacodynamics in patients with ALS.
Zydus Lifesciences bags USFDA approval for type 2 diabetes mellitus drug Zituvio for adults Ruchika Sharma21 Oct 2023 11:19 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA)...
Zydus ropes in Punit Patel as President, CEO to lead business operations in North America Ruchika Sharma16 Oct 2023 11:10 AM ISTAhmedabad: Zydus Lifesciences Limited, a discovery-driven, global lifesciences company has announced the appointment of Punit Patel as President and...
Zydus Lifesciences unit recalls over 7000 bottles of overactive bladder drug Oxybutynin Chloride in US Ruchika Sharma14 Oct 2023 11:44 AM ISTThe lot was produced at Ahmedabad and distributed in the US by Zydus Pharmaceuticals (USA) Inc, the US health regulator stated.
Zydus bags USFDA approval for Sugammadex Injection Ruchika Sharma7 Oct 2023 10:00 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food and Drug Administration ...
Zydus gets CDSCO permission to begin PCSK9 inhibitor Phase I clinical study Ruchika Sharma30 Sept 2023 12:30 PM ISTAhmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that it has received permission from CDSCO, India to initiate the...
Zydus bags USFDA nod for acne gel Clindamycin Phosphate Ruchika Sharma21 Sept 2023 11:30 AM ISTThe drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad, India.
Zydus Lifesciences gets USFDA EIR for formulation manufacturing facility at SEZ 2, Ahmedabad Ruchika Sharma20 Sept 2023 11:19 AM ISTAhmedabad: Zydus Lifesciences has announced that the company has received the Establishment Investigation Report (EIR) report from...
Zydus Lifesciences bags USFDA nod for Norelgestromin, Ethinyl Estradiol Transdermal System to prevent pregnancy Ruchika Sharma15 Sept 2023 3:40 PM ISTThe transdermal patch will be manufactured at the group's formulation manufacturing facility at Moraiya, Ahmedabad.
Zydus receives EIR for injectables manufacturing facility at Zydus Biotech Park, Ahmedabad Ruchika Sharma13 Sept 2023 4:18 PM ISTAhmedabad: Zydus Lifesciences has announced that the company has received the Establishment Investigation Report (EIR) report from...
Zydus Lifesciences incorporates wholly owned subsidiary company in Canada Ruchika Sharma9 Sept 2023 10:59 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has incorporated a wholly owned subsidiary company namely Zydus Pharmaceuticals...
Zydus Lifesciences bags USFDA nod for antibacterial drug Erythromycin Ruchika Sharma1 Sept 2023 3:28 PM ISTThe drug will be manufactured at the group’s formulation manufacturing facility in SEZ, Ahmedabad, India.
